These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 36791595)
21. Effective binding of free iron by a single intravenous dose of human apotransferrin in haematological stem cell transplant patients. Sahlstedt L; von Bonsdorff L; Ebeling F; Ruutu T; Parkkinen J Br J Haematol; 2002 Nov; 119(2):547-53. PubMed ID: 12406099 [TBL] [Abstract][Full Text] [Related]
22. Non-transferrin-bound iron assay system utilizing a conventional automated analyzer. Ito S; Ikuta K; Kato D; Shibusa K; Niizeki N; Tanaka H; Addo L; Toki Y; Hatayama M; Inamura J; Shindo M; Sasaki K; Iizuka N; Fujiya M; Torimoto Y; Kohgo Y Clin Chim Acta; 2014 Nov; 437():129-35. PubMed ID: 25072389 [TBL] [Abstract][Full Text] [Related]
23. Non-transferrin-bound serum iron (NTBI) in megaloblastic anemia: effect of vitamin B(12) treatment. Gafter-Gvili A; Prokocimer M; Breuer W; Cabantchik IZ; Hershko C Hematol J; 2004; 5(1):32-4. PubMed ID: 14745427 [TBL] [Abstract][Full Text] [Related]
24. [Non-transferrin-bound iron: a promising biomarker in iron overload disorders]. Maas RP; Voets PJ; de Swart L; Swinkels DW Ned Tijdschr Geneeskd; 2013; 157(49):A6258. PubMed ID: 24299624 [TBL] [Abstract][Full Text] [Related]
25. The Impact of Iron Overload in Acute Leukemia: Chronic Inflammation, But Not the Presence of Nontransferrin Bound Iron is a Determinant of Oxidative Stress. Olcay L; Serteser M; Kolay M; Balci HF; Yildirim ÜM; Tekgündüz SA; Hazirolan T; Terzi YK J Pediatr Hematol Oncol; 2017 Aug; 39(6):425-439. PubMed ID: 28731917 [TBL] [Abstract][Full Text] [Related]
26. The clinical relevance of detectable plasma iron species in iron overload states and subsequent to intravenous iron-carbohydrate administration. Garbowski MW; Cabantchik I; Hershko C; Hider R; Porter JB Am J Hematol; 2023 Mar; 98(3):533-540. PubMed ID: 36565452 [TBL] [Abstract][Full Text] [Related]
28. Transport of Non-Transferrin Bound Iron to the Brain: Implications for Alzheimer's Disease. Tripathi AK; Karmakar S; Asthana A; Ashok A; Desai V; Baksi S; Singh N J Alzheimers Dis; 2017; 58(4):1109-1119. PubMed ID: 28550259 [TBL] [Abstract][Full Text] [Related]
29. The assessment of serum nontransferrin-bound iron in chelation therapy and iron supplementation. Breuer W; Ronson A; Slotki IN; Abramov A; Hershko C; Cabantchik ZI Blood; 2000 May; 95(9):2975-82. PubMed ID: 10779448 [TBL] [Abstract][Full Text] [Related]
30. Quantifying non-transferrin-bound iron (NTBI) in human plasma: incorporating BODIPY-pyridylhydrazone (BODIPY-PH) within a thin green film linked to a portable fluorescence-based device. Naksen P; Chansaenpak K; Jungsuttiwong S; Intayot R; Jakmunee J; Pencharee S; Lieberzeit P; Jarujamrus P Anal Bioanal Chem; 2024 Sep; 416(23):5025-5035. PubMed ID: 39028344 [TBL] [Abstract][Full Text] [Related]
31. Results of an international round robin for the quantification of serum non-transferrin-bound iron: Need for defining standardization and a clinically relevant isoform. Jacobs EM; Hendriks JC; van Tits BL; Evans PJ; Breuer W; Liu DY; Jansen EH; Jauhiainen K; Sturm B; Porter JB; Scheiber-Mojdehkar B; von Bonsdorff L; Cabantchik ZI; Hider RC; Swinkels DW Anal Biochem; 2005 Jun; 341(2):241-50. PubMed ID: 15907869 [TBL] [Abstract][Full Text] [Related]
32. Removal of non-transferrin-bound iron from blood with iron overload using a device with immobilized desferrioxamine. Ambrus CM; Stadler I; Toumbis CA; Stadler A; Anthone S; Anthone R; DeAlarcon P; Deshpande G; Conway J; Vladutiu AO; Ambrus JL J Med; 1999; 30(3-4):211-24. PubMed ID: 17312675 [TBL] [Abstract][Full Text] [Related]
33. Improved quantification for non-transferrin-bound iron measurement using high-performance liquid chromatography by reducing iron contamination. Sasaki K; Ikuta K; Tanaka H; Ohtake T; Torimoto Y; Fujiya M; Kohgo Y Mol Med Rep; 2011; 4(5):913-8. PubMed ID: 21720715 [TBL] [Abstract][Full Text] [Related]
34. Fluorescence assay of non-transferrin-bound iron in thalassemic sera using bacterial siderophore. Sharma M; Saxena R; Gohil NK Anal Biochem; 2009 Nov; 394(2):186-91. PubMed ID: 19632191 [TBL] [Abstract][Full Text] [Related]
35. Iron overload across the spectrum of non-transfusion-dependent thalassaemias: role of erythropoiesis, splenectomy and transfusions. Porter JB; Cappellini MD; Kattamis A; Viprakasit V; Musallam KM; Zhu Z; Taher AT Br J Haematol; 2017 Jan; 176(2):288-299. PubMed ID: 27917462 [TBL] [Abstract][Full Text] [Related]
36. Intestinal absorption and enterohepatic cycling of biliary iron originating from plasma non-transferrin-bound iron in rats. Brissot P; Bolder U; Schteingart CD; Arnaud J; Hofmann AF Hepatology; 1997 Jun; 25(6):1457-61. PubMed ID: 9185768 [TBL] [Abstract][Full Text] [Related]
37. Impact of oral iron challenges on circulating non-transferrin-bound iron in healthy Guatemalan males. Schümann K; Kroll S; Romero-Abal ME; Georgiou NA; Marx JJ; Weiss G; Solomons NW Ann Nutr Metab; 2012; 60(2):98-107. PubMed ID: 22398912 [TBL] [Abstract][Full Text] [Related]
38. Bicarbonate inhibits the growth of Staphylococcus epidermidis in platelet concentrates by lowering the level of non-transferrin-bound iron. Matinaho S; Karhumäki P; Parkkinen J Transfusion; 2005 Nov; 45(11):1768-73. PubMed ID: 16271102 [TBL] [Abstract][Full Text] [Related]
39. Non-transferrin-bound iron is present in serum of hereditary haemochromatosis heterozygotes. de Valk B; Addicks MA; Gosriwatana I; Lu S; Hider RC; Marx JJ Eur J Clin Invest; 2000 Mar; 30(3):248-51. PubMed ID: 10692002 [TBL] [Abstract][Full Text] [Related]
40. Curcumin contributes to in vitro removal of non-transferrin bound iron by deferiprone and desferrioxamine in thalassemic plasma. Srichairatanakool S; Thephinlap C; Phisalaphong C; Porter JB; Fucharoen S Med Chem; 2007 Sep; 3(5):469-74. PubMed ID: 17897073 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]